NHLBI AIDS Program

Why is HIV-Related Heart, Lung, and Blood Research Important?

The NHLBI was swept up in the earliest research activities as the AIDS epidemic engulfed the globe. The impact of HIV threw into stark relief concerns about the safety of the blood supply and transformed transfusion medicine. The dramatic events of the past thirty-two years have converted this acute, rapidly lethal illness into a chronic disease. Elucidating the biology of infection, understanding the nuances of the immune response, and developing effective therapies have dramatically changed the landscape.

Living for many decades with HIV is now the norm. The long-term consequences of infection, inflammation and chronic administration of antiretroviral therapy on the function of the heart, lung, blood, blood vessels, and bone marrow are becoming evident. As a result, a whole new set of questions arise: Are cardiovascular, pulmonary and hematologic disorders more common in persons living with HIV? Do they occur earlier? Do they manifest differently? How do these sets of exposures and processes interact with other risk factors for disease such as smoking, hypertension, and dyslipidemia?

The complex interactions between the blood, bone marrow, vasculature, and cardiovascular and pulmonary systems provide an opportunity for research to expand our understanding of the environmental and genetic factors determining health and disease. Such research also has the potential to clarify the impact of processes that underlie damage to multiple organs and enhance the care of persons with HIV and other chronic diseases. The NHLBI AIDS research program aims to prepare for the consequences of stunning successes in management of complex conditions and to bring multiple disciplines together to tackle emerging challenges.

About the NHLBI AIDS Program

Monica Shah, MD - NHLBI AIDS Coordinator

How Does NHLBI Support HIV-Related Research?

The NHLBI has a robust portfolio of HIV-related grants that are managed in its three divisions. HIV-related pediatric research is managed within the heart, lung, or blood division most relevant to the research content. The goals, past successes and future interests of the NHLBI AIDS Program are described in the About AIDS Program section.

• HIV-Related Research in the Division of Cardiovascular Sciences
• HIV-Related Research in the Division of Lung Diseases
• HIV-Related Research in the Division of Blood Diseases and Resources
• HIV-Related Research in Pediatric Heart Lung and Blood Diseases

Highlighted Topics

• Spotlight on Research: 3 Part Series about the NHLBI AIDS Program
  • NHLBI AIDS Program Addresses Increasing Burden of Chronic Disease for HIV-Infected Individuals – The Heart
  • NHLBI AIDS Program Looks at Lung Diseases in HIV-Infected Individuals
  • NHLBI AIDS Program Examines Potential of Stem Cells, Other Treatments to Cure HIV
• NHLBI AIDS Working Group Recommendations
• NHLBI AIDS Working Group Manuscript: Hematopoeitic cell transplantation and HIV cure: where we are and what next?(592 KB)
• AIDS Research at NHLBI (1008 KB)
• NHLBI Presentation at 2013 Conference on Retroviruses and Opportunistic Infections
  HIV-Related Cardiovascular Disease: Predicting Risk and Monitoring Outcomes (1809 KB)